Traditional cyclophotocoagulation has typically been reserved for patients with poor vision and end-stage glaucoma, but the use of a safer micropulse technique has allowed the expansion of this treatment option to patients with moderate and/or severe glaucoma. The procedure works by decreasing aqueous production either through ciliary body ablation or through increasing uveoscleral outflow with an 810 nm laser, but does not involve incisions, thus essentially eliminating the risk of bleeding or infection. Micropulse CPC is applicable also to patients with contraindications to incisional glaucoma surgery which may include elderly patients, patients who are at an increased risk of fall, and patients who are unable to make frequent postoperative visits.
|Title of host publication
|Operative Dictations in Ophthalmology
|Springer International Publishing
|Number of pages
|Published - 24 Apr 2017
- Trans-scleral cyclophotocoagulation (CPC)
- Trans-scleral diode laser CPC